Q4 2018 Seres Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Seres Therapeutics Conference Call. As a reminder, this conference is being recorded and will be available on Seres' website for replay. And I would now like to introduce your host for today's call, Dr. Carlo Tanzi, Vice President, Investor Relations and Corporate Communications. Please go ahead.
Thank you, Josh, and good morning. A press release with the company's fourth quarter and full year 2018 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors and Media section of the company's website.
I'd like to remind you that we'll be making forward-looking statements relating to our development plans; the impact of our recent corporate changes; the timing of the ECOSPOR III study and its ability to support approval; the promise and potential impact of any of our microbiome therapeutics or clinical trial data; the expected regulatory requirements for the SER-287 Phase
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
